Cover Image
市場調查報告書 - 117225

成體幹細胞和iPS細胞(人工多功能幹細胞)市場:2010年

Adult Stem Cells and iPSCs 2010 Market Report

出版商 SELECTBIO, Ltd. (selectbiosciences.com)
出版日期 內容資訊 英文
價格
本報告書已不再販售
成體幹細胞和iPS細胞(人工多功能幹細胞)市場:2010年 Adult Stem Cells and iPSCs 2010 Market Report
出版日期: 2010年03月01日 內容資訊: 英文

本報告已在2013年10月24日停止出版

簡介

本報告,彙整了成體幹細胞和iPS細胞(人工多功能幹細胞)市場的定量•定性的動向,與全球的智慧財產權、相關法規、治療領域等,由下列摘要形式闡述。

第1章 報告檢視

第2章 成體幹細胞:特性、特徵、市場分析

  • MSC的特性
  • 創造MSC的特徵的標記
  • MSC所調整的免疫調整效果
  • MSC的複合功能
  • MSC調整組織修復的機制
  • 再生醫療上的MSC的作用機制 其他

第3章 心血管疾病

  • 心血管疾病的細胞療法
  • MSC於心血管修復的作用機制
  • 心血管疾病的MSC細胞療法的傳遞途徑
  • 幹細胞療法對於心血管疾病的安全性問題
  • 缺血性症狀的持續以及近年已完成的臨床試驗
  • 再生IHD臨床試驗
  • 肢缺血 其他

第4章 中樞神經疾病

  • 中樞神經疾病的幹細胞療法
  • MSC的神經修復效果
  • 缺血性腦中風的神經幹細胞
  • 慢性兒童型腦硬化症的神經幹細胞

第5章 糖尿病

  • 糖尿病的細胞療法
  • ASC衍生
  • hESC衍生
  • Trans-Differentiation衍生

第6章 iPS細胞

  • iPS細胞領域的里程碑
  • iPS細胞領域的專業用語的定義
  • iPS細胞的優點與缺點
  • 基因重組的小分子
  • 基因重組因素的傳遞法
  • iPS細胞市場分析:創造市場動向特徵的市場調查資料

附錄1:調查方式

附錄2:iPS細胞專利環境

附錄3:EU的iPS細胞相關法規

目錄

Abstract

This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and this market report maps this landscape with particular emphasis on the characteristics of adult stem cells which leverage their utilization for cellular therapy/regenerative medicine.

This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our deep analysis of this space provides up-to-date qualitative and quantitative market metrics. Primary Market Data Provide a Comprehensive and Bottom-Up Picture of the Space for Adult Stem Cells as wells as for iPSCs.

In this market report, we provide a technical, market (global research trends), intellectual property, and a regulatory map of the iPSC space that is granular and up-to-date.

Specific Topics Covered in this Report:

  • Qualitative and Quantitative Trends in the Adult and iPSCs Space: Quantitative Market Forecast (Market Size) by Product Class in the Stem Cells Space and Corresponding Growth Rates
  • Primary Market Survey Data Derived from a Worldwide Pool of Industry Participants Presents the Market Landscape for iPSCs
  • Worldwide Intellectual Property (IP) Landscape for iPSCs as its Exists Today: Presents the Scope of the Issued IP as well as filings in various aspects of iPSC production - Important for Benchmarking Research & Development Programs
  • Regulatory Landscape of iPSCs Across the European Union
  • Therapeutic Areas Impacted by Adult Stem Cells
  • Mesenchymal Stem Cells (MSCs) for Cellular Therapy: Detailed Presentation of the MSC Space From a Technical Perspective: Phenotype, Characteristics, Mechanisms of Action

An important feature of this market report are the extensive primary market analysis data including primary market survey data from worldwide respondent pools of stem cell research, especially in the emerging, fast-moving iPSC market:

  • Characterizes the iPSC Marketplace in Detail
  • Provides End-User Research Trends Currently Practiced in the iPSCs Space

This data-driven characterization of the stem cells landscape as it relates to adult stem cells and iPSCs is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development - all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling "drag-and-drop" into business presentations/business plans.

Extensive Worldwide Technical and Market Analyses Presented in this Report:

  • Worldwide Total Quantitative Market Opportunity and Growth in the Stem Cells Space
  • Mesenchymal Stem Cells [MSCs] for Cellular Therapy/Regenerative Medicine
  • Mechanism of Action of MSCs in Cellular Therapy/Regenerative Medicine: Mechanism of MSC-mediated Tissue Repair
  • Clinical Trials Deploying MSCs in Various Therapeutic Areas: Quantitative Market Breakout and Characteristics
  • Other Types of Adult Stem Cells and their Penetrance in Cellular Therap
  • Business Models in the Cellular Therapy Space
  • Cellular Therapy of Cardiovascular and CNS Diseases: Market Characteristics
  • iPSCs: Technical Characteristics, Current Worldwide Research Market Trends
  • iPSCs: Intellectual Property (IP) Landscape Analysis with Description of Scope of Filed IP and Issued IP
  • iPSCs: Regulatory Trends Across the European Union (EU)
  • More details of the scope of coverage of this industry report are found in the Table of Contents (TOC) for the report - see below for link to downloadable PDF of the TOC

This data-driven characterization of the microRNA research landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development - all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling "drag-and-drop" into business presentations/business plans.

Table of Contents

Scope and Description of Chapters in the Report

Chapter I. Executive Overview of the Space

  • 1. Scope of this Market Report
  • 2. Differentiation of ESCs to Clinically-Relevant Populations
  • 3. Timeline of impact of Various Stem Cell Types on the Research and Cellular Therapy Markets
  • 4. Market Sizing and Growth Rate
  • 5. Breakout of Worldwide Stem Cell Industry Revenues in 2010

Chapter II. Adult Stem Cells: Properties, Characteristics, and Market Analysis

  • 1. Properties of MSCs
  • 2. Markers that Characterize MSCs
  • 3. Immunomodulatory Effects Mediated by MSCs
  • 4. Multipotency of MSCs
  • 5. Mechanisms of MSC-mediated Tissue Repair
  • 6. Proposed Mechanism of Action of MSCs in Regenerative Medicine In Vivo
  • 7. Regenerative Medicine Elicited by MSCs
  • 8. 2010 Stem Cell Product Category Market Shares
  • 9. Breakout of Worldwide Clinical Trials Deploying MSCs as Therapeutics: By Disease Area Targeted
  • 10. Breakout of Worldwide Clinical Trials Deploying MSCs as Therapeutics: By Patient Recruitment Status
  • 11. Breakout of Worldwide Clinical Trials Deploying MSCs as Therapeutics: By Clinical Trial Phase
  • 12. Worldwide Clinical Trials Deploying NSCs as Therapeutics
  • 13. Companies Focused in the Regenerative Medicine/Cellular Therapy Space Worldwide: Breakout by Therapeutic Class Addressed
  • 14. Stem Cells Market Segmentation
  • 15. Business Models in the Cellular Therapy Space, Utilizing Adult

Chapter III. Cardiovascular Diseases

  • 1. Cellular Therapy for Cardiovascular Disease
  • 2. Proposed Mechanisms of MSC-Mediated Cardiovascular Repair
  • 3. Potential Delivery Routes of MSC-based Cellular Therapy for Cardiovascular Disease
  • 4. Safety Concerns with Stem Cell Therapy for Cardiovascular Diseases
  • 5. Ongoing and Recently-Completed Clinical Trials for Ischemic Conditions
  • 6. The REGENERATE-IHD Clinical Trial
  • 7. Critical Limb Ischemia
  • 8. IMPACT-DEM Clinical Trial
  • 9. RESTORE-CLI Clinical Trial

Chapter IV. CNS Diseases

  • 1. Stem Cell Treatments for CNS Disorders
  • 2. Neurorestorative Effects of MSCs
  • 3. Neural Stem Cells (NSCs) for Ischemic Stroke
  • 4. NSCs for Pelizaeus - Merzbacher Disease

Chapter V. Diabetes

  • 1. Cellular Therapy of Diabetes
  • 2. ASC - derived
  • 3. hESC - derived
  • 4. Trans - differentiation - derived

Chapter VI. iPSCs

  • 1. Milestones in the iPSCs Space
  • 2. Glossary of Terms in the iPSCs Space
  • 3. Advantages and Challenges of iPSCs Space
  • 4. Small Molecules for Reprogramming
  • 5. Methods of Delivery of Reprogramming Factors
  • 6. iPSCs Market Analysis: Primary Market Survey Data to Characterize Research Market Trends
  • 7. Penetrance of Various hESC Lines in Research Practice Today

Appendix I. Research Methodology

Appendix II. iPSC Patent Landscape

Appendix III. iPSC Requlatory Trends Across the European Union

Back to Top